BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24938757)

  • 1. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
    Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
    BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
    Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
    J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Yang W; Wu X
    Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
    Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
    Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.
    Kusada T; Toita T; Ariga T; Maemoto H; Hashimoto S; Shiina H; Kakinohana Y; Heianna J; Nagai Y; Kudaka W; Aoki Y; Murayama S
    J Radiat Res; 2018 Jan; 59(1):67-76. PubMed ID: 29186565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.
    Bandyopadhyay A; Ghosh AK; Chhatui B; Das D
    Rep Pract Oncol Radiother; 2021; 26(2):170-178. PubMed ID: 34211766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.
    Paton AM; Chalmers KE; Coomber H; Cameron AL
    Br J Radiol; 2012 Dec; 85(1020):e1249-55. PubMed ID: 23175490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-based image-guided brachytherapy in uterine cervical cancer: Effect of tumor dose and volume on local control.
    Uezono H; Tsujino K; Inoue Y; Kajihara A; Marudai M; Bessho R; Sekii S; Kubota H; Yamaguchi S; Ota Y
    Brachytherapy; 2022; 21(6):814-822. PubMed ID: 36155168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of conformal computed tomography (CT)-based intracavitary brachytherapy (ICBT) for locally advanced cervical cancer: a single institution's experience.
    Tharavichitkul E; Mayurasakorn S; Lorvidhaya V; Sukthomya V; Wanwilairat S; Lookaew S; Pukanhaphan N; Chitapanarux I; Galalae R
    J Radiat Res; 2011; 52(5):634-40. PubMed ID: 21952319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
    Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
    Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
    Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
    J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.